Please click here for Prescribing Information and Medication Guide.
If you are struggling to lower your blood sugar to get to goal on your current therapy, Victoza® may be able to help. Victoza® is a noninsulin, injectable, once-a-day diabetes medication that lowers blood sugar in adults and children 10 years of age and older with type 2 diabetes in several ways.
In medical studies of adults with type 2 diabetes, many of those taking Victoza® were able to reach the American Diabetes Association's A1C goal of less than 7.0%. (The A1C test measures your average blood sugar level over the previous 2 to 3 months.) Victoza® helps lower blood sugar for most nonpregnant adults in as soon as 2 weeks, and has been shown to keep it down in a 2-year medical study.
Victoza® 1.8 mg taken alone or in combination with other diabetes medications lowered A1C in adults by 1.0% to 1.5%, on average, in medical studies. That's good to know, because even a 1% drop in A1C can be important in the management of type 2 diabetes.
Victoza® works like the hormone glucagon-like peptide-1 (GLP-1) (7-37)a to:
aGLP-1 (7-37) represents <20% of the total circulating GLP-1 produced by your body.
In clinical studies of adults with type 2 diabetes, ranging from 26 to 52 weeks in length, many lost some weight. In a large study, when Victoza® was added to metformin, adults lost on average up to 6.2 pounds. While many adults in clinical trials lost weight, some did gain weight. The American Diabetes Association recommends weight loss as an important goal for overweight people with type 2 diabetes.
Whether you’re new to Victoza® or have been taking it for some time, Novo Nordisk offers advice and inspiration that can help you start off right and stay on track with managing your diabetes.
Victoza® may cause serious side effects, including:
Do not use Victoza® if:
Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is an injectable prescription medicine used:
Victoza® is not for use in people with type 1 diabetes. It should not be used with other medicines that contain liraglutide. It is not known if Victoza® is safe and effective to lower blood sugar in children under 10 years of age.
Before using Victoza®, tell your health care provider if you:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.
Victoza® may cause serious side effects, including:
The most common side effects of Victoza® may include nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation.
Please click here for Prescribing Information and Medication Guide.
Victoza® is a prescription medication.
Novo Nordisk provides patient assistance for those who qualify.
Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Victoza® may cause serious side effects, including:
Do not use Victoza® if:
Victoza® (liraglutide) injection 1.2 mg or 1.8 mg is an injectable prescription medicine used:
Victoza® is not for use in people with type 1 diabetes. It should not be used with other medicines that contain liraglutide. It is not known if Victoza® is safe and effective to lower blood sugar in children under 10 years of age.
Before using Victoza®, tell your health care provider if you:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.
Victoza® may cause serious side effects, including:
The most common side effects of Victoza® may include nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation.
Please click here for Prescribing Information and Medication Guide.
Victoza® is a prescription medication.
Novo Nordisk provides patient assistance for those who qualify.
Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.